AJ

Abdul Jalil Miah

Active Director Additional Director DIN 10911701
DIN 10911701 First appointment Jan 2025
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value •••• Premium profile

About Abdul Jalil Miah

Data last updated:

Abdul Jalil Miah is an Additional Director at Triventis Pharma Private Limited (since 2025). Triventis Pharma Private Limited reported revenue of ₹40,128 (FY 2025).

DIN 10911701
Primary Designation Additional Director
First Appointment 14 Jan 2025
Oldest Company Age 3 yrs
Largest company Triventis Pharma Private Limited · ₹40,128 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Triventis Pharma Private Limited U47721AS2023PTC024904
Additional Director14 Jan 20252023₹40,128 (FY 2025)Active

Board colleagues of Abdul Jalil Miah

Directorship timeline

Open interactive timeline →
Triventis Pharma Private Limited
Premium access

Shareholding and investment profile for Abdul Jalil Miah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Jalil Miah

Abdul Jalil Miah currently holds 1 directorship: Triventis Pharma Private Limited (Additional Director, since 14 Jan 2025, revenue ₹40,128 (FY 2025)).

Abdul Jalil Miah was first appointed on 14 Jan 2025 as Additional Director at Triventis Pharma Private Limited.

The current boards of Abdul Jalil Miah's companies include Monowar Hussain Ahmed (Triventis Pharma Private Limited), Moynul Hoque (Triventis Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available